HOPO Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$226M
- Investors
-
7
HOPO Therapeutics General Information
Description
Operator of a clinical-stage pharmaceutical company designed to develop treatments for heavy metal poisoning and pioneer novel methods for directed radioisotope delivery. The company offers proprietary technologies licensed from Lawrence Berkeley National Laboratory, enabling healthcare providers to combat contamination from radioactive materials and emerging contaminants while improving patient outcomes and advancing medical treatment.
Contact Information
Website
www.hopotx.comCorporate Office
- 5858 Horton Street
- Suite 393
- Emeryville, CA 94608
- United States
Corporate Office
- 5858 Horton Street
- Suite 393
- Emeryville, CA 94608
- United States
HOPO Therapeutics Timeline
HOPO Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 28-Oct-2024 | $226M | Completed | Clinical Trials - Phase 1 | ||
| 6. Grant | 02-Nov-2023 | Completed | Clinical Trials - Phase 1 | |||
| 5. Accelerator/Incubator | 12-Jul-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 3. Accelerator/Incubator | 22-Jun-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 06-Jun-2023 | $2M | $2M | Completed | Clinical Trials - Phase 1 | |
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 |
HOPO Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
HOPO Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HOPO Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| U.S. Department of Energy | Government | |||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Ferocity Capital | Venture Capital | Minority | ||
| Little Green Bamboo Capital | Venture Capital | Minority | ||
| Activate Global | Accelerator/Incubator |
HOPO Therapeutics FAQs
-
When was HOPO Therapeutics founded?
HOPO Therapeutics was founded in 2020.
-
Where is HOPO Therapeutics headquartered?
HOPO Therapeutics is headquartered in Emeryville, CA.
-
What is the size of HOPO Therapeutics?
HOPO Therapeutics has 15 total employees.
-
What industry is HOPO Therapeutics in?
HOPO Therapeutics’s primary industry is Drug Discovery.
-
Is HOPO Therapeutics a private or public company?
HOPO Therapeutics is a Private company.
-
What is HOPO Therapeutics’s current revenue?
The current revenue for HOPO Therapeutics is .
-
How much funding has HOPO Therapeutics raised over time?
HOPO Therapeutics has raised $2M.
-
Who are HOPO Therapeutics’s investors?
U.S. Department of Energy, Creative Destruction Lab, Ferocity Capital, Little Green Bamboo Capital, and Activate Global are 5 of 7 investors who have invested in HOPO Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
